Literature DB >> 28685085

Diffuse fluorodeoxyglucose-positron uptake in the bone marrow of a patient with granulocyte colony-stimulating factor-producing pleomorphic carcinoma of the lung: A case report.

Takashi Makino1, Yoshinobu Hata1, Hajime Otsuka1, Satoshi Koezuka1, Nao Kikuchi2, Kazutoshi Isobe2, Naobumi Tochigi3, Kazutoshi Shibuya3, Sakae Homma2, Akira Iyoda1.   

Abstract

The current study presents the case of a 66-year-old male presenting with fever and chest pain. Chest enhanced computed tomography scanning revealed a mass shadow in the right upper lobe with chest wall invasion. 18-Fluorodeoxyglucose-positron emission tomography (FDG-PET) identified the localized uptake of the mass lesion in the right upper lobe, in addition to diffuse uptake by the bone marrow. The laboratory data on admission revealed marked leukocytosis and an elevated C-reactive protein level (CRP). Serum concentrations of granulocyte colony-stimulating factor (G-CSF) and interleukin 6 were increased. Based on a clinical diagnosis of non-small cell lung cancer (c-T3N0M0 stage IIB), the patient underwent right upper lobectomy with chest wall resection. The histological examination showed a pulmonary pleomorphic carcinoma. Immunohistochemical analysis of the resected tumor tissues revealed positive staining for G-CSF. The patient's high-grade fever, leukocytosis, and elevated CRP level rapidly subsided following the resection. This confirmed that the tumor was a G-CSF-producing pulmonary pleomorphic carcinoma. Five months after the resection, the diffuse FDG uptake in the bone marrow was absent, even with the presence of a small pulmonary metastasis and marginal serum G-CSF elevation. Diffuse FDG uptake in bone marrow induced by G-CSF producing pleomorphic carcinoma must be taken into consideration, in order for it not to be misinterpreted as diffuse bone marrow metastases or hematologic malignancy.

Entities:  

Keywords:  FDG-PET; G-CSF; lung cancer; pleomorphic carcinoma; surgery

Year:  2017        PMID: 28685085      PMCID: PMC5492683          DOI: 10.3892/mco.2017.1271

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  16 in total

Review 1.  The new World Health Organization classification of lung tumours.

Authors:  E Brambilla; W D Travis; T V Colby; B Corrin; Y Shimosato
Journal:  Eur Respir J       Date:  2001-12       Impact factor: 16.671

2.  Granulocyte colony-stimulating factor and interleukin-6-producing lung cancer cell line, LCAM.

Authors:  M Inoue; M Minami; Y Fujii; H Matsuda; R Shirakura; T Kido
Journal:  J Surg Oncol       Date:  1997-04       Impact factor: 3.454

Review 3.  G-CSF induces focal intense bone marrow FDG uptake mimicking multiple bone metastases from uterine cervical cancer: a case report and review of the literature.

Authors:  S Mabuchi; A Morimoto; M Fujita; K Isohashi; T Kimura
Journal:  Eur J Gynaecol Oncol       Date:  2012       Impact factor: 0.196

4.  Establishment of a large cell lung cancer cell line (Y-ML-1B) producing granulocyte colony-stimulating factor.

Authors:  Yoshitaka Sekido; Mitsuo Sato; Noriyasu Usami; Kikuo Shigemitsu; Shoichi Mori; Osamu Maeda; Toyoharu Yokoi; Yoshinori Hasegawa; Hiromu Yoshioka; Kaoru Shimokata
Journal:  Cancer Genet Cytogenet       Date:  2002-08

5.  Constitutive production of granulocyte colony-stimulating factor and interleukin-6 by a human lung cancer cell line, KSNY: gene amplification and increased mRNA stability.

Authors:  T Matsuguchi; S Okamura; C Kawasaki; K Shimoda; F Omori; S Hayashi; N Kimura; Y Niho
Journal:  Eur J Haematol       Date:  1991-08       Impact factor: 2.997

6.  Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy.

Authors:  Y Sugawara; S J Fisher; K R Zasadny; P V Kison; L H Baker; R L Wahl
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

Review 7.  Interleukin-6 signaling pathway in targeted therapy for cancer.

Authors:  Yuqi Guo; Feng Xu; TianJian Lu; Zhenfeng Duan; Zhan Zhang
Journal:  Cancer Treat Rev       Date:  2012-05-29       Impact factor: 12.111

8.  Establishment of large cell lung cancer cell lines secreting hematopoietic factors inducing leukocytosis and thrombocytosis.

Authors:  H Kimura; Y Yamaguchi; L Sun; S Iwagami; K Sugita
Journal:  Jpn J Clin Oncol       Date:  1992-10       Impact factor: 3.019

9.  Serum levels of cytokines in patients with untreated primary lung cancer.

Authors:  N Katsumata; K Eguchi; M Fukuda; N Yamamoto; Y Ohe; F Oshita; T Tamura; T Shinkai; N Saijo
Journal:  Clin Cancer Res       Date:  1996-03       Impact factor: 12.531

10.  Colony-stimulating factor-producing tumours: production of granulocyte colony-stimulating factor and interleukin-6 is secondary to interleukin-1 production.

Authors:  R Tsuyuoka; T Takahashi; Y Sasaki; Y Taniguchi; M Fukumoto; A Suzuki; K Nakamura; S Kobayashi; T Kudo; K Nakao
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

View more
  5 in total

1.  G-CSF-producing left lung squamous cell carcinoma positive for ROS1 rearrangements completely resected after neoadjuvant radiation chemotherapy: A case report.

Authors:  Hironobu Samejima; Naoko Ose; Teiko Sakurai; Hideki Nagata; Eiichi Morii; Yasushi Shintani
Journal:  Respir Med Case Rep       Date:  2022-06-27

2.  G-CSF-producing Undifferentiated Pleomorphic Sarcoma Adjacent to the Ascending Colon and in the Right Iliopsoas Muscle: A Case Report and Review of the Literature.

Authors:  Shinsuke Kazama; Tabu Gokita; Michitoshi Takano; Ayataka Ishikawa; Yu Nishimura; Hiroaki Ishii; Yusuke Nishizawa; Yoji Nishimura; Yoshiyuki Kawashima; Hirohiko Sakamoto
Journal:  Intern Med       Date:  2019-06-27       Impact factor: 1.271

3.  Favorable response to pembrolizumab in granulocyte colony-stimulating factor-producing upper urinary tract urothelial carcinoma.

Authors:  Hiroki Takeda; Ryuji Matsumoto; Emi Takakuwa; Kanta Hori; Takuya Moriguchi; Shuhei Yamada; Hiroshi Kikuchi; Takahiro Osawa; Takashige Abe; Nobuo Shinohara
Journal:  IJU Case Rep       Date:  2021-12-17

4.  Programmed cell death ligand 1 measurement study in granulocyte colony-stimulating factor-producing lung cancer: an observational study.

Authors:  Kazuhito Miyazaki; Aya Shiba; Toshiki Ikeda; Yuko Higashi; Masaharu Aga; Yusuke Hamakawa; Yuri Taniguchi; Yuki Misumi; Yoko Agemi; Yukiko Nakamura; Tsuneo Shimokawa; Hiroaki Okamoto
Journal:  BMC Cancer       Date:  2022-09-13       Impact factor: 4.638

Review 5.  Imaging findings of granulocyte colony-stimulating factor-producing tumors: a case series and review of the literature.

Authors:  Shigeshi Kohno; Akihiro Furuta; Shigeki Arizono; Koji Tokunaga; Sei Nakao; Masahiro Tanabe; Tatsuki R Kataoka; Hiroyoshi Isoda; Kaori Togashi
Journal:  Jpn J Radiol       Date:  2021-05-22       Impact factor: 2.374

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.